Departamento de Cuidado Critico Pediatrico, Red Colaborativa Pediátrica de Latinoamérica (LARed Network), Montevideo, Uruguay.
Departamento de Pediatria, Cuidados Intensivos Pediátricos y Neonatales (CINP), Medica Uruguaya, Montevideo, Uruguay.
Pediatr Pulmonol. 2021 Feb;56(2):384-391. doi: 10.1002/ppul.25212. Epub 2020 Dec 17.
Care variability for children with severe acute asthma has been well documented in high-income countries, yet data from low- and middle-income regions are lacking. We sought to characterize the magnitude of practice variability in the care of Latin American children to identify opportunities for standardization of care.
A cross-sectional study performed through a retrospective analysis of contemporaneously collected data of children with severe acute asthma admitted to a center contributing to the LARed Network registry between May 2017 and May 2019. Centers were grouped by geographic location: Atlantic (AT), South Pacific (SP), and North Central (NC).
Among 434 children, most received care in hospitals in the AT group (54% [235/434]), followed by the NC (23% [101/434]) and SP (23% [98/434]) groups. The majority of children in the AT (92% [215/235]) and SP (91% [89/98]) groups received nebulized salbutamol/albuterol, while metered-dose inhalers were preferred in the NC group (72% [73/101]). There was a wide variation in the use of antibiotics: AT (57% [135/235]), SP (48% [47/98]), and NC (14% [14/101]). The same was true for ipratropium bromide: AT (67% [157/235]), SP (90% [88/98]), and NC (17% [17/101]), and aminophylline: AT (57% [135/235]), NC (5% [5/101]), and SP (0% [0/98]). High-flow nasal cannula was the preferred respiratory support modality in the AT (60% [141/235]) and NC (40% [40/101]) groups, while bilevel positive airway pressure (BiPAP) use was more common in the SP group (80% [78/98]).
We identified significant variability in care for severe acute asthma. Our findings will help to inform the design of future studies, quality improvement initiatives, and development of practice guidelines within Latin America.
在高收入国家,严重急性哮喘患儿的护理变异性已有充分记录,但中低收入地区的数据却很缺乏。我们试图描述拉丁美洲儿童护理中实践变异性的程度,以确定护理标准化的机会。
这是一项通过回顾性分析 2017 年 5 月至 2019 年 5 月期间参与 LARed 网络注册中心的严重急性哮喘患儿的同期采集数据进行的横断面研究。中心按地理位置分组:大西洋(AT)、南太平洋(SP)和中北部(NC)。
在 434 名儿童中,大多数在 AT 组的医院接受治疗(54%[235/434]),其次是 NC 组(23%[101/434])和 SP 组(23%[98/434])。AT(92%[215/235])和 SP(91%[89/98])组的大多数儿童接受了沙丁胺醇/特布他林雾化吸入,而 NC 组则更喜欢使用计量吸入器(72%[73/101])。抗生素的使用差异很大:AT(57%[135/235])、SP(48%[47/98])和 NC(14%[14/101])。同样,溴化异丙托品的使用也存在差异:AT(67%[157/235])、SP(90%[88/98])和 NC(17%[17/101]);氨茶碱:AT(57%[135/235])、NC(5%[5/101])和 SP(0%[0/98])。高流量鼻导管是 AT(60%[141/235])和 NC(40%[40/101])组中首选的呼吸支持方式,而双水平气道正压通气(BiPAP)在 SP 组中更为常见(80%[78/98])。
我们发现严重急性哮喘的护理存在显著差异。我们的发现将有助于为未来的研究、质量改进举措以及拉丁美洲实践指南的制定提供信息。